Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Use of the Cerebro-placental Ratio to Predict Adverse Outcomes in Pregnancies Complicated by Gestational Diabetes

NCT03072563 is registered in ClinicalTrials.gov with Unity Health Toronto as lead sponsor.

NCT NCT03072563
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03072563 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Use of the Cerebro-placental Ratio to Predict Adverse Outcomes in Pregnancies Complicated by Gestational Diabetes
Lead sponsor
Unity Health Toronto
Phase
Observational
Overall status
Unknown status
Start date
March 7, 2017
Completion date
March 7, 2021
Enrollment
207 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gestational diabetes